Exelixis Inc
NASDAQ: EXEL
$35.80
+$0.29 (+0.8%)
Closing Price on November 7, 2024
EXEL Stock Chart and Intraday Price
EXEL Stock Data
| Asset Type | Stock |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | TRADE & SERVICES |
| Industry | SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH |
| Address | 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, US |
| Fiscal Year End | December |
| Latest Quarter | 12/31/2023 |
| Market Cap | 6,743.03M USD |
| Shares Outstanding | 303,194,000 |
EXEL Articles
In the past week, insiders returned to scoop up more shares of a fracking services company and a recreational boat maker.
Published:
Public offerings of stock tempted some insider buying, and one insider stepped up to support a struggling online delivery service provider.
Published:
Friday's top analyst upgrades and downgrades included Datadog, DexCom, Exelixis, Lam Research, Las Vegas Sands, Lyft, Match, Nasdaq, Next Era Energy, Norfolk Southern, Pfizer, Walmart and Wolfspeed.
Published:
Thursday's top analyst upgrades and downgrades included AT&T, Alibaba, Ally Financial, BioMarin Pharmaceutical, Box, Citrix Systems, Nio, Schlumberger and TJX Companies.
Published:
Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including BioNTech, Denali Therapeutics, Exelixis, Foot Locker and Hostess Brands.
Published:
Thursday's top analyst upgrades and downgrades included Adobe, Baker Hughes, Best Buy, Cisco Systems, CyberArk Software, Enphase Energy, Grubhub, Jumia Technologies, SmileDirectClub, Under Armour and...
Published:
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study.
Published:
The top analyst upgrades, downgrades and initiations seen on Monday included Chipotle Mexican Grill, Delphi Technologies, Dollar General, Facebook, Ingersoll-Rand, Nike, Okta and Quest Diagnostics.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Friday included Biogen, Broadcom, Citigroup, Equifax, Fitbit, Intel, Kraft Heinz, Merck, Roku, Under Armour, United Technologies and...
Published:
Last Updated:
The biotech team at SunTrust feel that it would not be a major surprise to see these six top companies post quarterly results that beat top-line Wall Street expectations.
Published:
Last Updated:
Sears, Weyerhaeuser, Laredo Petroleum, and Exelixis were among the stocks posting new 52-week lows Monday.
Published:
Last Updated:
Exelixis shares dipped on Monday after the company announced that it has initiated a late-stage trial in patients with radioiodine-refractory differentiated thyroid cancer (DTC).
Published:
Last Updated:
JD.com, Turquoise Hills, Exelixis, and Floor & Decor Holdings all posted new 52-week lows Monday.
Published:
Last Updated:
Invesco, Tal Education, Chemours, and Exelixis all posted new 52-week lows on Thursday.
Published:
Last Updated: